Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


Articles published in AJNR Am J Neuroradiol

Retrieve available abstracts of 24 articles:
HTML format
Text format



Single Articles


    October 2018
  1. LEE JJ, Shimony JS, Jafri H, Zazulia AR, et al
    Hemodynamic Impairment Measured by Positron-Emission Tomography Is Regionally Associated with Decreased Cortical Thickness in Moyamoya Phenomenon.
    AJNR Am J Neuroradiol. 2018 Oct 25. pii: ajnr.A5812. doi: 10.3174/ajnr.A5812.
    PubMed     Text format     Abstract available


    September 2018
  2. SHANG K, Wang J, Fan X, Cui B, et al
    Clinical Value of Hybrid TOF-PET/MR Imaging-Based Multiparametric Imaging in Localizing Seizure Focus in Patients with MRI-Negative Temporal Lobe Epilepsy.
    AJNR Am J Neuroradiol. 2018 Sep 20. pii: ajnr.A5814. doi: 10.3174/ajnr.A5814.
    PubMed     Text format     Abstract available


  3. SAKAGUCHI Y, Kidokoro H, Ogawa C, Okai Y, et al
    Longitudinal Findings of MRI and PET in West Syndrome with Subtle Focal Cortical Dysplasia.
    AJNR Am J Neuroradiol. 2018 Sep 13. pii: ajnr.A5772. doi: 10.3174/ajnr.A5772.
    PubMed     Text format     Abstract available


    August 2018
  4. WANGARYATTAWANICH P, Branstetter BF 4th, Hughes M, Clump DA 2nd, et al
    Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
    AJNR Am J Neuroradiol. 2018 Aug 30. pii: ajnr.A5767. doi: 10.3174/ajnr.A5767.
    PubMed     Text format     Abstract available


    June 2018
  5. KIM YI, Kim Y, Lee JY, Jang SJ, et al
    Prognostic Value of the Metabolic and Volumetric Parameters of (11)C-Methionine Positron-Emission Tomography for Gliomas: A Systematic Review and Meta-Analysis.
    AJNR Am J Neuroradiol. 2018 Jun 28. pii: ajnr.A5707. doi: 10.3174/ajnr.A5707.
    PubMed     Text format     Abstract available


    January 2018
  6. SAKATA A, Okada T, Yamamoto Y, Fushimi Y, et al
    Addition of Amide Proton Transfer Imaging to FDG-PET/CT Improves Diagnostic Accuracy in Glioma Grading: A Preliminary Study Using the Continuous Net Reclassification Analysis.
    AJNR Am J Neuroradiol. 2018 Jan 4. pii: ajnr.A5503. doi: 10.3174/ajnr.A5503.
    PubMed     Text format     Abstract available


    December 2017
  7. LI H, Deng L, Bai HX, Sun J, et al
    Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis.
    AJNR Am J Neuroradiol. 2017 Dec 14. pii: ajnr.A5472. doi: 10.3174/ajnr.A5472.
    PubMed     Text format     Abstract available


    August 2017
  8. JENKINS NW, Talbott JF, Shah V, Pandit P, et al
    [18F]-Sodium Fluoride PET MR-Based Localization and Quantification of Bone Turnover as a Biomarker for Facet Joint-Induced Disability.
    AJNR Am J Neuroradiol. 2017 Aug 31. doi: 10.3174/ajnr.A5348.
    PubMed     Text format     Abstract available


    July 2017
  9. KALE HA, Muthukrishnan A, Hegde SV, Agarwal V, et al
    Intracranial Perishunt Catheter Fluid Collections with Edema, a Sign of Shunt Malfunction: Correlation of CT/MRI and Nuclear Medicine Findings.
    AJNR Am J Neuroradiol. 2017 Jul 13. doi: 10.3174/ajnr.A5291.
    PubMed     Text format     Abstract available


    June 2017
  10. TOMURA N, Kokubun M, Saginoya T, Mizuno Y, et al
    Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among 11C-Methionine-PET, FDG-PET, MR Permeability Imaging, and MRI-ADC-Preliminary Results.
    AJNR Am J Neuroradiol. 2017 Jun 15. doi: 10.3174/ajnr.A5252.
    PubMed     Text format     Abstract available


  11. KANETA T, Katsuse O, Hirano T, Ogawa W, et al
    Head-to-Head Visual Comparison between Brain Perfusion SPECT and Arterial Spin-Labeling MRI with Different Postlabeling Delays in Alzheimer Disease.
    AJNR Am J Neuroradiol. 2017 Jun 1. doi: 10.3174/ajnr.A5238.
    PubMed     Text format     Abstract available


  12. KRIEGER DA, Hudgins PA, Nayak GK, Baugnon KL, et al
    Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
    AJNR Am J Neuroradiol. 2017;38:1193-1199.
    PubMed     Text format     Abstract available


    May 2017
  13. MATIAS-GUIU JA, Cabrera-Martin MN, Matias-Guiu J, Carreras JL, et al
    FDG-PET/CT or MRI for the Diagnosis of Primary Progressive Aphasia?
    AJNR Am J Neuroradiol. 2017 May 25. doi: 10.3174/ajnr.A5255.
    PubMed     Text format    


  14. DELGADO AF, Delgado AF
    Discrimination between Glioma Grades II and III Using Dynamic Susceptibility Perfusion MRI: A Meta-Analysis.
    AJNR Am J Neuroradiol. 2017 May 18. doi: 10.3174/ajnr.A5218.
    PubMed     Text format     Abstract available


  15. YAMAUCHI H, Kagawa S, Kishibe Y, Takahashi M, et al
    Progressive Cortical Neuronal Damage and Extracranial-Intracranial Bypass Surgery in Patients with Misery Perfusion.
    AJNR Am J Neuroradiol. 2017;38:935-941.
    PubMed     Text format     Abstract available


    April 2017
  16. RICHTER V, Helle M, van Osch MJ, Lindner T, et al
    MR Imaging of Individual Perfusion Reorganization Using Superselective Pseudocontinuous Arterial Spin-Labeling in Patients with Complex Extracranial Steno-Occlusive Disease.
    AJNR Am J Neuroradiol. 2017;38:703-711.
    PubMed     Text format     Abstract available


    March 2017
  17. CHIANG GC, Mao X, Kang G, Chang E, et al
    Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET.
    AJNR Am J Neuroradiol. 2017 Mar 24. doi: 10.3174/ajnr.A5143.
    PubMed     Text format     Abstract available


  18. JENA A, Taneja S, Jha A, Damesha NK, et al
    Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study.
    AJNR Am J Neuroradiol. 2017 Mar 24. doi: 10.3174/ajnr.A5124.
    PubMed     Text format     Abstract available


  19. IVANIDZE J, Charalel RA, Shuryak I, Brenner D, et al
    Effects of Radiation Exposure on the Cost-Effectiveness of CT Angiography and Perfusion Imaging in Aneurysmal Subarachnoid Hemorrhage.
    AJNR Am J Neuroradiol. 2017;38:462-468.
    PubMed     Text format     Abstract available


    February 2017
  20. HIREMATH SB, Muraleedharan A, Kumar S, Nagesh C, et al
    Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma?
    AJNR Am J Neuroradiol. 2017 Feb 16. doi: 10.3174/ajnr.A5089.
    PubMed     Text format     Abstract available


    January 2017
  21. CUVINCIUC V, Viallon M, Barnaure I, Vargas MI, et al
    Dynamic Contrast-Enhanced MR Perfusion of Intradural Spinal Lesions.
    AJNR Am J Neuroradiol. 2017;38:192-194.
    PubMed     Text format     Abstract available


  22. WU J, Dehkharghani S, Nahab F, Allen J, et al
    The Effects of Acetazolamide on the Evaluation of Cerebral Hemodynamics and Functional Connectivity Using Blood Oxygen Level-Dependent MR Imaging in Patients with Chronic Steno-Occlusive Disease of the Anterior Circulation.
    AJNR Am J Neuroradiol. 2017;38:139-145.
    PubMed     Text format     Abstract available


    December 2016
  23. LIN X, Lee M, Buck O, Woo KM, et al
    Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  24. HOJJAT SP, Kincal M, Vitorino R, Cantrell CG, et al
    Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: